Increased air pollution in recent years has exacerbated health risks for people who suffer from pulmonary diseases and these dynamics underscore the importance of increasing the efficacy of drug delivery devices that administer active pharmaceutical ingredients to treat respiratory illnesses. Researchers describe developing a computational evaluation of drug delivery through both pressurized metered-dose inhalers and dry powder inhalers to determine how the process can be improved.